GO:0016032 viral process: Infection, Replication, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016032 viral process is a biological_process defined as a multi-organism process in which a virus is a participant and the other participant is the host, encompassing infection of a host cell, replication of the viral genome, and assembly of progeny virus particles.
• The term includes both lytic and persistent outcomes, and in some cases viral genetic material may integrate into the host genome and only later complete its life cycle.
• Studying viral process requires methods that resolve host-pathogen interactions at the molecular level, including live-cell imaging of viral entry and mass spectrometry-based virological sciences.
• Clinical virology depends on amplification chemistries that detect viral genomes during infection, making viral process a central framework for diagnostic assay design.
• Evolutionary virology shows that viral process is shaped by long-term host-virus coevolution, with implications for emergence and virulence.
• Host factors such as kallikreins and connexins are emerging as regulators and effectors of viral infection, linking viral process to cardiovascular and other disease phenotypes.
Description
GO:0016032 viral process is the Gene Ontology biological_process term that describes the entire multi-organism interaction in which a virus participates and a host is the other participant. It covers infection of a host cell, replication of the viral genome, and assembly of progeny virus particles, and it explicitly allows for integration of viral genetic material into the host genome followed by later completion of the life cycle. Because it is a multi-organism process rather than a single molecular event, viral process provides a unifying framework for interpreting virology experiments across disciplines, from entry to egress. The term is central to modern virology because it connects molecular mechanisms to clinical outcomes and to the evolutionary dynamics of host-pathogen systems. Researchers use GO:0016032 to annotate gene products that participate in any stage of the viral life cycle, which makes it a powerful entry point for functional genomics and drug-target discovery. As virology education and research continue to expand, standardized ontology terms such as viral process enable reproducible comparison of results across laboratories and model systems.
viral process At A Glance
| GO ID | GO:0016032 |
|---|---|
| GO term | viral process |
| Ontology | biological_process |
| Synonym | viral infection; virulence; virus process |
| Major function | Multi-organism process in which a virus infects a host cell, replicates its genome, and assembles progeny virus particles |
| Definition source | QuickGO definition: A multi-organism process in which a virus is a participant; the other participant is the host; includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles; in some cases viral genetic material may integrate into the host genome and only subsequently complete its life cycle |
| Taxonomic scope | Viruses and their hosts across all domains of life |
| Related processes | Viral entry, viral genome replication, virion assembly, viral latency and integration |
| Research relevance | Central framework for virology, antiviral target discovery, diagnostic assay design, and host-pathogen interaction studies |
What Is GO:0016032?
In plain terms, GO:0016032 viral process describes everything that happens when a virus interacts with a host: the virus enters a host cell, copies its genome, builds new virus particles, and sometimes inserts its genetic material into the host genome so that it can complete its life cycle later. The QuickGO definition frames this as a multi-organism process in which a virus is a participant and the host is the other participant, and it explicitly includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. The definition also notes that in some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, complete its life cycle. Synonyms for this term include viral infection, virulence, and virus process.
Why Is viral process Important in Cell Biology?
GO:0016032 viral process matters because it provides a standardized, ontology-based description of the entire host-virus interaction, enabling researchers to annotate, compare, and integrate data from molecular virology, clinical diagnostics, and evolutionary studies. Because the term spans entry, genome replication, assembly, and possible integration, it supports systems-level analyses of how viruses manipulate host cells and how host factors such as kallikreins and connexins influence infection outcomes. This breadth makes viral process indispensable for antiviral discovery, vaccine development, and understanding viral contributions to chronic disease.
• Provides a shared vocabulary for annotating viral and host genes across all stages of infection.
• Supports antiviral target discovery by linking molecular mechanisms to specific life-cycle steps.
• Underpins clinical virology diagnostics that rely on amplification chemistries to detect viral genomes during infection.
• Enables evolutionary analyses of virulence, host range, and emergence within a defined process framework.
• Connects viral entry mechanisms to live-cell imaging and quantitative infection assays.
• Highlights host regulators such as kallikreins that modulate viral infections and may be therapeutically targeted.
• Links viral infection to cardiovascular dysfunction through connexin dysregulation in the heart.
• Facilitates comparative virology education and reproducible experimental design across model systems.
• Provides a framework for studying viral latency and genome integration as part of the viral life cycle.
• Enables integration of proteomics and mass spectrometry data into functional models of infection.
What Happens During viral process?
Host cell recognition and viral entry
In simple terms: The virus first attaches to a host cell and gets inside.
Viral process begins when a virus recognizes and binds to a host cell and then enters it, a step that can be visualized in real time using live-cell imaging approaches. Entry is a multi-organism interaction because it requires both viral attachment factors and host cell surface components, and it determines tropism and the subsequent course of infection. Mass spectrometry-based virological sciences have been used to identify viral and host proteins that participate in these early events.
Viral genome replication
In simple terms: Once inside, the virus makes many copies of its genetic material.
After entry, the viral genome is replicated using viral and/or host machinery, and this step is a core component of the GO:0016032 definition. Replication strategies differ among virus families, but all are annotated under viral process because they occur within the multi-organism context of infection. Clinical virology relies on amplification chemistries to detect viral genomes during this phase, which is why replication is a key target for diagnostic assays.
Assembly of progeny virus particles
In simple terms: New viral parts are put together to form complete virus particles.
The definition of GO:0016032 explicitly includes assembly of progeny virus particles, meaning that structural components and viral genomes are brought together to form new virions. Assembly is coordinated with genome replication and can be studied using proteomic and imaging methods that resolve viral and host contributions. This stage is a major focus for antiviral strategies that aim to block the production of infectious particles.
Integration and latency
In simple terms: Some viruses can insert their genes into the host genome and wait before completing their life cycle.
The QuickGO definition notes that in some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, complete its life cycle. This latent or integrated state is part of viral process and has important implications for persistence and reactivation. Evolutionary virology studies show that such integration events can shape long-term host-virus relationships.
Host factors and modulation of infection
In simple terms: Host proteins can help or hinder the virus at every step.
Host factors such as kallikreins have emerged as new regulators of viral infections, influencing the efficiency of viral process. Connexin dysfunction in the heart during viral infection illustrates how host cell communication proteins can be affected by viral process and contribute to organ-level pathology. These examples show that viral process is not solely a viral program but a multi-organism interaction shaped by host genetics.
Key Genes Involved in GO:0016032 viral process
The following genes and proteins are representative participants or regulators of viral process, based on published virology literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACE2 | Host receptor for SARS-CoV-2 entry | Target for entry-blocking studies and KO models of viral entry |
| TMPRSS2 | Host protease that primes viral spike protein for entry | Point-mutation and KO models to test entry efficiency |
| Kallikrein-related peptidases (KLKs) | Emerging regulators of viral infections | Overexpression and KO models to dissect host regulation of viral process |
| Connexins (e.g., Cx43) | Gap junction proteins affected during viral infection in the heart | Knock-in and KO models to study viral effects on cardiac connexin function |
| IFNAR1 | Type I interferon receptor mediating antiviral responses | KO models to test interferon control of viral process |
| STAT1 | Interferon signaling transcription factor | KO and point-mutation models to study antiviral gene expression |
| MX1 | Interferon-induced antiviral effector | Overexpression and KO models to test restriction of viral replication |
| OAS1 | Interferon-induced antiviral enzyme | KO models to assess viral genome degradation pathways |
| PKR (EIF2AK2) | Interferon-induced kinase that inhibits translation during infection | Point-mutation models to separate kinase and non-kinase functions |
| APOBEC3G | Cytidine deaminase restricting retroviral replication | Overexpression and KO models to study viral genome mutation |
| TRIM5 | Restriction factor targeting retroviral capsids | Knock-in models to test species-specific restriction |
| SAMHD1 | dNTP hydrolase restricting retroviral replication | KO and point-mutation models to study dNTP pools in viral process |
| BST2 (Tetherin) | Restriction factor that retains virions at the cell surface | Overexpression models to block virion release |
| CCR5 | Co-receptor for HIV entry | KO models and clinical relevance for HIV resistance |
| CXCR4 | Co-receptor for HIV entry | KO and point-mutation models to study tropism |
| IRF3 | Transcription factor driving interferon responses | KO models to test innate immune control of viral process |
| NF-kB subunits | Transcription factors modulating antiviral and inflammatory responses | KO and reporter knock-in models to study viral activation of signaling |
| ATG5 | Autophagy protein involved in antiviral defense | KO models to test autophagy-virus interactions |
How Is viral process Regulated?
Viral process is regulated at multiple levels by host and viral factors. Host interferon signaling through IFNAR1 and STAT1 induces antiviral effectors such as MX1, OAS1, PKR, and APOBEC3G that restrict different stages of the viral life cycle. Kallikreins have emerged as new regulators of viral infections, indicating that extracellular proteolytic pathways can modulate viral process. In the heart, viral infection is associated with connexin dysfunction, showing that viral process can dysregulate host cell communication and contribute to organ pathology. Viral proteins themselves also regulate the process by counteracting host restriction factors and by controlling the timing of genome replication, assembly, and latency. Evolutionary analyses further indicate that host-virus coevolution shapes the regulatory landscape of viral process over time.
viral process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCR5 | HIV resistance and viral entry | KO cell model to test entry blockade |
| Connexins (e.g., Cx43) | Viral infection and connexin dysfunction in the heart | Knock-in and KO models in cardiac cells |
| Kallikrein-related peptidases | Regulation of viral infections | Overexpression and KO models to test viral replication |
| IFNAR1 | Antiviral interferon response | KO models to assess viral susceptibility |
| APOBEC3G | Retroviral restriction | Overexpression models to study viral genome mutation |
Viral infection and cardiovascular dysfunction
Viral process is directly linked to cardiovascular pathology, as viral infection can cause connexin dysfunction in the heart and contribute to arrhythmias and myocardial dysfunction. This connection highlights the need for models that capture how viral process alters gap junction proteins and cardiac conduction. Studying viral process in cardiac cells can reveal host factors that protect or exacerbate infection-related heart disease.
Viral infection and host protease regulation
Kallikreins have emerged as new regulators of viral infections, linking proteolytic pathways to the efficiency of viral process. Dysregulation of these pathways may influence susceptibility to viral disease and could represent a therapeutic target. Experimental models that manipulate kallikrein expression are therefore valuable for understanding viral pathogenesis.
Viral latency, integration, and chronic disease
Because GO:0016032 includes integration of viral genetic material into the host genome followed by later completion of the life cycle, it provides a framework for studying chronic and reactivating viral diseases. Latent or integrated viral genomes can persist for years and are relevant to cancers and other chronic conditions associated with viral infection. Evolutionary virology further shows that integration and coevolution can shape long-term host outcomes.
Clinical virology and diagnostics
Clinical virology depends on amplification chemistries to detect viral genomes during infection, making viral process a practical framework for diagnostic assay development. Mass spectrometry-based approaches have also been applied in virological sciences to identify viral and host proteins involved in infection. These diagnostic and analytical advances are essential for monitoring viral disease and guiding treatment.
From viral process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate host gene restrict viral entry? | KO cell model plus viral entry assay |
| Does a point mutation in a restriction factor alter antiviral activity? | Point-mutation knock-in cell model |
| Can a host factor be tagged to track its localization during infection? | Tagged knock-in cell model |
| Does overexpression of a host factor enhance or block viral replication? | Overexpression cell model |
| Which host genes are essential for viral process? | Genome-wide CRISPR library screening |
| How does viral infection change host gene expression? | RNA-seq and bioinformatics analysis |
How to Study the viral process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time viral entry and intracellular trafficking | Dissecting early steps of viral process |
| Mass spectrometry | Viral and host proteins and complexes | Identifying interactors in virological sciences |
| Amplification chemistries (PCR) | Viral genome copies | Clinical detection and viral load monitoring |
| RNA-seq | Host and viral transcript abundance | Measuring gene expression changes during infection |
| CRISPR library screening | Host genes required for viral process | Genome-wide discovery of essential host factors |
| Proteomics | Protein abundance and modifications | Mapping host responses to viral infection |
| Phylogenetics | Evolutionary relationships of viruses | Studying viral emergence and virulence |
Live-cell imaging of viral entry
Live-cell imaging allows researchers to visualize viral entry in real time, revealing the dynamics of attachment, internalization, and intracellular trafficking during viral process. This method is particularly useful for distinguishing entry pathways and for testing inhibitors that block early steps.
Mass spectrometry in virological sciences
Mass spectrometry-based proteomics has been applied broadly in virological sciences to identify viral and host proteins, post-translational modifications, and protein complexes involved in viral process. It enables unbiased discovery of host factors that interact with viral components during infection.
Amplification chemistries for viral genome detection
Clinical virology relies on amplification chemistries to detect and quantify viral genomes during infection, providing direct evidence that viral genome replication is occurring. These methods are essential for diagnosis, viral load monitoring, and evaluating antiviral interventions.
Evolutionary and comparative virology approaches
Evolutionary virology uses comparative sequence analysis and phylogenetic methods to study how viral process and host-virus interactions change over time. These approaches help explain virulence, host range, and emergence patterns.
How CRISPR Can Be Used to Study GO:0016032 viral process
Knockout
CRISPR knockout cell models are used to delete candidate host genes and test whether they are required for viral process, such as entry, genome replication, or assembly. For example, knocking out a suspected receptor or restriction factor can reveal its role in infection. Knockout screens across the genome can identify host dependencies of viral process.
Point Mutation
Point-mutation knock-in models allow precise testing of amino acid residues that control host factor activity during viral process, such as catalytic sites in restriction enzymes or receptor-binding interfaces. These models help distinguish loss-of-function from separation-of-function phenotypes. They are especially useful when complete knockout is lethal or confounds interpretation.
Knock-in
Knock-in models can introduce tags, reporters, or humanized alleles to track host and viral components during viral process. Tagged knock-in of host factors enables imaging and proteomic analysis of their localization and interactions during infection. Humanized knock-in models can also make animal or cell systems permissive to human viruses.
Overexpression
Overexpression models are used to test whether increasing the level of a host factor enhances or blocks viral process. For example, overexpressing a restriction factor can suppress viral replication, while overexpressing a proviral factor can increase infection. These models complement knockout studies by providing gain-of-function evidence.
How EDITGENE Supports viral process Research
Researchers studying viral process-related genes often need to determine whether a candidate gene is causally involved in infection, replication, or assembly, and CRISPR-based models provide the most direct way to test causality. EDITGENE offers a comprehensive suite of services to generate and characterize such models, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for viral process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| PARD6A Knockout HEK293 Cell Line | EDJ-KQ1342 | Human | 50855 | Details Get a Quote |
| CALCOCO2 Knockout HEK293 Cell Line | EDJ-KQ2730 | Human | 10241 | Details Get a Quote |
| CCL1 Knockout HEK293 Cell Line | EDJ-KQ5726 | Human | 6346 | Details Get a Quote |
| HCFC2 Knockout HEK293 Cell Line | EDJ-KQ9080 | Human | 29915 | Details Get a Quote |
| TP53 Knockout HEK293 Cell Line | EDJ-KQ17910 | Human | 7157 | Details Get a Quote |
| TP53 Knockout hTERT-RPE1 Cell Line | EDC00205 | Human | 7157 | Details Get a Quote |
| TP53 Knockout HeLa Cell Line | EDJ-KQ18086 | Human | 7157 | Details Get a Quote |
| TP53 Knockout A-549 Cell Line | EDJ-KQ18198 | Human | 7157 | Details Get a Quote |
| PARD6A Knockout A-549 Cell Line | EDJ-KQ19463 | Human | 50855 | Details Get a Quote |
| PARD6A Knockout HCT 116 Cell Line | EDJ-KQ20808 | Human | 50855 | Details Get a Quote |
| PARD6A Knockout HeLa Cell Line | EDJ-KQ20809 | Human | 50855 | Details Get a Quote |
| CALCOCO2 Knockout A-549 Cell Line | EDJ-KQ23593 | Human | 10241 | Details Get a Quote |
| CALCOCO2 Knockout HCT 116 Cell Line | EDJ-KQ23594 | Human | 10241 | Details Get a Quote |
| CALCOCO2 Knockout HeLa Cell Line | EDJ-KQ23595 | Human | 10241 | Details Get a Quote |
Displaying Records 1 To 15 Of 54 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About viral process
What is GO:0016032 viral process?
GO:0016032 viral process is a Gene Ontology biological_process term defined as a multi-organism process in which a virus is a participant and the host is the other participant, including infection of a host cell, replication of the viral genome, and assembly of progeny virus particles.
What genes are involved in viral process?
Genes involved in viral process include host receptors such as ACE2, proteases such as TMPRSS2, restriction factors such as APOBEC3G and TRIM5, interferon pathway components such as IFNAR1 and STAT1, and emerging regulators such as kallikreins and connexins.
What are the stages of viral process?
The main stages are host cell recognition and entry, viral genome replication, assembly of progeny virus particles, and in some cases integration into the host genome followed by later completion of the life cycle.
How is viral process studied?
Viral process is studied using live-cell imaging of entry, mass spectrometry-based proteomics, amplification chemistries for viral genome detection, and evolutionary analyses.
Why is viral process important for disease?
Viral process is important because it underlies viral infections that cause acute and chronic diseases, including cardiovascular dysfunction through connexin dysregulation and conditions linked to viral integration.
What is the role of kallikreins in viral infections?
Kallikreins have emerged as new regulators of viral infections, indicating that extracellular proteolytic pathways can modulate viral process.
How does viral infection affect the heart?
Viral infection can cause connexin dysfunction in the heart, which may contribute to cardiac pathology.
What methods detect viral genome replication?
Amplification chemistries such as PCR are used in clinical virology to detect and quantify viral genomes during infection.
Can CRISPR be used to study viral process?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can be used to test host gene function in viral process, and CRISPR library screens can identify essential host factors.
What is the difference between viral process and viral infection?
Viral infection is a synonym for viral process in GO:0016032, which also includes replication of the viral genome, assembly of progeny virus particles, and possible integration into the host genome.
Conclusion
GO:0016032 viral process provides a comprehensive ontology framework for studying how viruses infect hosts, replicate their genomes, assemble progeny particles, and sometimes integrate into host DNA. Its breadth makes it valuable for molecular virology, clinical diagnostics, evolutionary biology, and drug discovery. By combining CRISPR models with imaging, proteomics, and screening approaches, researchers can dissect the host and viral determinants of viral process and translate these insights into new antiviral strategies.
References
- 1. Giritch A et al.. 2017. 125 years of virology and ascentof biotechnologies based on viral expression.. Tsitol Genet 51(2):19-39 PMID: 30484616
- 2. Milewska A et al.. 2020. MASS SPECTROMETRY IN VIROLOGICAL SCIENCES.. Mass Spectrom Rev 39(5-6):499-522 PMID: 31876329
- 3. Dunbar S et al.. 2019. Amplification chemistries in clinical virology.. J Clin Virol 115:18-31 PMID: 30953805
- 4. Maginnis MS. 2025. The Future of Virology Education.. Annu Rev Virol 12(1):43-57 PMID: 40312283
- 5. Geoghegan JL et al.. 2018. Evolutionary Virology at 40.. Genetics 210(4):1151-1162 PMID: 30523166
- 6. Sun E et al.. 2013. Live cell imaging of viral entry.. Curr Opin Virol 3(1):34-43 PMID: 23395264
- 7. Pampalakis G et al.. 2021. Kallikreins emerge as new regulators of viral infections.. Cell Mol Life Sci 78(21-22):6735-6744 PMID: 34459952
- 8. Phillips CM et al.. 2025. Viral Infection and Connexin Dysfunction in the Heart.. Curr Cardiol Rep 27(1):76 PMID: 40146392
